Skip to main content
Erschienen in: Breast Cancer 4/2017

12.11.2016 | Original Article

Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip®) placed in phantoms and patients

verfasst von: Naomi Sakamoto, Yukari Ogawa, Yuko Tsunoda, Eisuke Fukuma

Erschienen in: Breast Cancer | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the usefulness of the UltraClip® dual trigger breast tissue marker (UltraClip) for sonographic localization, we investigate the sonographic visibility and sonographic appearance of the UltraClip placed in phantoms and patients.

Materials and methods

Ten UltraClips were placed in the target lesions in the phantoms. After the ultrasound examination of the UltraClip, the ultrasound images were compared to the real appearance of the UltraClip obtained by cutting the phantoms. In the patient, the UltraClip markers were placed after biopsy of a suspicious breast lesion or before or during neoadjuvant chemotherapy. The patients consented to return 1–3 weeks after the procedure for ultrasound imaging of the UltraClip.

Results

The UltraClip placed in the phantom appeared as a hyperechoic structure with a mean maximum diameter of 5.5 mm, which was found to correspond to the metallic clip in 90% (9/10) of the cases, and as a hyperechoic tubular structure with a maximum diameter of 9.0 mm corresponded to the expanded polyvinyl alcohol polymer in the remaining 10% (1/10) of cases. On the other hand, the UltraClip was detected as a hyperechoic structure measuring 3.5 mm in size only in 9 of the 15 (60%) patients. The sonographic visibility of the UltraClip was not affected depending on whether the target lesion or post-biopsy scar was sonographically detectable or not [60% (6/10) vs. 60% (3/5)].

Conclusions

While sonographic localization by targeting the UltraClip may be useful in 60% of the patients, another localization technique will be needed in the remaining patients.
Literatur
1.
Zurück zum Zitat Ahmed M, Douek M. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat. 2013;140:435–46.CrossRefPubMed Ahmed M, Douek M. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat. 2013;140:435–46.CrossRefPubMed
2.
Zurück zum Zitat Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9(10):994–8.CrossRefPubMed Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol. 2002;9(10):994–8.CrossRefPubMed
3.
Zurück zum Zitat Nurco J, Mancino AT, Whitacre E, Edwards MJ. Surgical benefits conveyed by biopsy site marking system using ultrasound localization. Am J Surg. 2005;190:618–22.CrossRef Nurco J, Mancino AT, Whitacre E, Edwards MJ. Surgical benefits conveyed by biopsy site marking system using ultrasound localization. Am J Surg. 2005;190:618–22.CrossRef
4.
Zurück zum Zitat Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR. 2003;181:1295–9.CrossRefPubMed Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR. 2003;181:1295–9.CrossRefPubMed
5.
Zurück zum Zitat Klein RL, Mook JA, Euhus DM, Rao R, Wynn RT, Eastman AB, et al. Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non-palpable breast lesions. J Surg Oncol. 2012;105(6):591–4.CrossRefPubMed Klein RL, Mook JA, Euhus DM, Rao R, Wynn RT, Eastman AB, et al. Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non-palpable breast lesions. J Surg Oncol. 2012;105(6):591–4.CrossRefPubMed
6.
Zurück zum Zitat Gittleman MA. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg. 2003;186(4):386–90.CrossRefPubMed Gittleman MA. Single-step ultrasound localization of breast lesions and lumpectomy procedure. Am J Surg. 2003;186(4):386–90.CrossRefPubMed
7.
Zurück zum Zitat Eby PR, Calhoun KE, Kurland BF, Demartini WB, Gutierrez RL, Peacock S, et al. Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips. Acad Radiol. 2010;17(3):340–7.CrossRefPubMed Eby PR, Calhoun KE, Kurland BF, Demartini WB, Gutierrez RL, Peacock S, et al. Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips. Acad Radiol. 2010;17(3):340–7.CrossRefPubMed
8.
Zurück zum Zitat Pinkney D, Shah A. Prospective comparative study to evaluate the sonographic visibility of five commercially available breast biopsy markers. J Diagn Medical Sonogr. 2013;29(4):151–8.CrossRef Pinkney D, Shah A. Prospective comparative study to evaluate the sonographic visibility of five commercially available breast biopsy markers. J Diagn Medical Sonogr. 2013;29(4):151–8.CrossRef
9.
Zurück zum Zitat Seow JH, Phillips M, Taylor D. Sonographic visibility of breast tissue markers: a tissue phantom comparison study. AJUM. 2012;15(4):149–57.PubMedPubMedCentral Seow JH, Phillips M, Taylor D. Sonographic visibility of breast tissue markers: a tissue phantom comparison study. AJUM. 2012;15(4):149–57.PubMedPubMedCentral
Metadaten
Titel
Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip®) placed in phantoms and patients
verfasst von
Naomi Sakamoto
Yukari Ogawa
Yuko Tsunoda
Eisuke Fukuma
Publikationsdatum
12.11.2016
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 4/2017
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-016-0741-0

Weitere Artikel der Ausgabe 4/2017

Breast Cancer 4/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.